B-Cell Malignant Neoplasm — Trials

B-Cell Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,465 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,083
Recruiting: 1,078
Ph III recruiting: 121
Growth YoY: +5.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,167)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00171925	Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I	terminated	Phase 3	143	Novartis PharmaceuticalsINDUSTRY	1	Apr 11, 2012	clinicaltrials
NCT00573391	Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2	terminated	Phase 3	5	University of ArkansasOTHER	1	Aug 12, 2011	clinicaltrials